CB2R-IN-1 is primarily utilized in research settings to study the role of the cannabinoid receptor type 2 (CB2R) in various physiological and pathological processes. It acts as a selective inhibitor of CB2R, making it a valuable tool for investigating the receptor's function in immune modulation, inflammation, and pain management. Researchers use this compound to explore its potential therapeutic applications in conditions such as autoimmune diseases, neuroinflammation, and chronic pain disorders. Additionally, CB2R-IN-1 aids in understanding the receptor's signaling pathways and its interaction with other cannabinoid receptors, contributing to the development of targeted therapies for CB2R-related disorders. Its application is largely confined to preclinical studies, where it helps elucidate the receptor's role in health and disease.